Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568
Nxera previously announced the initiation of the Phase 3 registrational program of NBI-'568 by Neurocrine in May 2025. The Phase 3 study is a global double-blind, placebo-controlled trial evaluating NBI-'568 in adults with a primary diagnosis of schizophrenia who are experiencing an acute exacerbation or relapse of symptoms. The study is expected to enroll approximately 280 patients. The primary endpoint of the study is a reduction from baseline in the Positive and Negative Syndrome Scale (PANSS). The key secondary endpoint is improvement in the Clinical Global Impression of Severity (CGI-S) scale.
–END–
About Nxera PharmaNxera Pharma is a technology powered biopharma company in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally.
We have built an agile, new-generation commercial business in Japan to develop and commercialize innovative medicines, including several launched products, to address this high value, large and growing market and those in the broader APAC region.
Behind that, and powered by our unique NxWave™ discovery platform, we are advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage internally and in partnership with leading pharma and biotech companies. This pipeline of potentially first- and best-in-class candidates is focused on addressing major unmet needs in some of the fastest-growing areas of medicine across neurology/neuropsychiatry, metabolic diseases and immunology and inflammation.
Nxera employs approximately 400 talented people at key locations in Tokyo and Osaka (Japan), London and Cambridge (UK), Basel (Switzerland) and Seoul (South Korea) and is listed on the Tokyo Stock Exchange (ticker: 4565).
For more information, please visit www.nxera.life LinkedIn: @NxeraPharma | X: @NxeraPharma | YouTube: @NxeraPharma
Enquiries:
Nxera – Media and Investor RelationsShinya Tsuzuki, VP, Head of Investor RelationsShinichiro Nishishita, VP Investor Relations, Head of Regulatory DisclosuresMaya Bennison, Communications Manager+81 (0)3 5962 5718 | +44 (0)1223 949390 |IR@Nxera.life
MEDiSTRAVA (for International Media)Mark Swallow, Frazer Hall, Erica Hollingsworth+44 (0)203 928 6900 | Nxera@medistrava.com
Forward-looking statements
This press release contains forward-looking statements, including statements about the discovery, development, and commercialization of products. Various risks may cause Nxera Pharma Group's actual results to differ materially from those expressed or implied by the forward looking statements, including: adverse results in clinical development programs; failure to obtain patent protection for inventions; commercial limitations imposed by patents owned or controlled by third parties; dependence upon strategic alliance partners to develop and commercialize products and services; difficulties or delays in obtaining regulatory approvals to market products and services resulting from development efforts; the requirement for substantial funding to conduct research and development and to expand commercialization activities; and product initiatives by competitors. As a result of these factors, prospective investors are cautioned not to rely on any forward-looking statements. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Trump's reciprocal tariffs could be struck down as soon as this month — and the administration is warning of economic apocalypse
President Donald Trump and his Justice Department have issued doomsday warnings recently on what would happen if a federal appeals court rules against the administration in a legal challenge to his so-called reciprocal tariffs. James Lucier at Alpha Capital Partners said the court could issue a ruling later this month or next month. The Trump administration sees complete disaster for the U.S. economy if its reciprocal tariffs are struck down, revealing its level of concern as a court is expected to issue a critical decision soon. On July 31, a federal appeals court heard arguments in a case challenging the tariffs' legal basis under the International Economic Emergency Powers Act (IEEPA), and the judges expressed deep skepticism about the administration's side. In a note this past week, James Lucier at Capital Alpha Partners said a decision is expected by the end of September, but could come as soon as late August. A unanimous or near-unanimous ruling could give the Supreme Court cover to avoid taking the case immediately and reject the administration's request to issue a stay that would keep the tariffs in place in the meantime. The dire warnings also represent 'a remarkable change in tune by the administration, which until now has always insisted that it had legal authority to get the deals done one way or another even if the IEEPA tariffs were struck down,' he added. Trump's 'Liberation Day' tariffs helped leverage a series of trade deals, including an agreement with the European Union, which pledged to invest $600 billion in the U.S. and buy $750 billion worth of U.S. energy products, with 'vast amounts' of American weapons in the mix. Similarly, the U.S.-Japan trade deal entails $550 billion of investments from Tokyo. 'Financial ruin' The U.S. hasn't received immediate cash transfers in those amounts. Still, in a letter to the U.S. Court of Appeals for the Federal Circuit on Monday, Justice Department officials suggested the government would suddenly owe everyone money—leading to catastrophe. 'The President believes that our country would not be able to pay back the trillions of dollars that other countries have already committed to pay, which could lead to financial ruin,' wrote Solicitor General D. John Sauer and Assistant Attorney General Brett Shumate. They also warned that unwinding the trade deals would lead to a '1929-style result.' That echoed a post from Trump on Truth Social days earlier, when he predicted another Great Depression would hit America if the court rules against his tariffs. Sauer and Shumate turned up the volume even higher in their subsequent letter, elaborating further on the depression warning. 'In such a scenario, people would be forced from their homes, millions of jobs would be eliminated, hard-working Americans would lose their savings, and even Social Security and Medicare could be threatened,' they wrote. 'In short, the economic consequences would be ruinous, instead of unprecedented success.' 'The president is in a jam' To be sure, the government has generated significant tariff revenue since April, and importers who paid the reciprocal duties could seek reimbursement if they are struck down. But that's only about $100 billion and also includes revenue from sectoral tariffs that were imposed under a separate legal basis that's not at risk. 'The real problem, the letter implies, is that Trump does not have legal authority to replicate the IEEPA tariffs under other tariff statutes if the court strikes the IEEPA tariffs down,' Lucier explained. 'In other words, the president is in a jam because if the court strikes down the IEEPA tariffs, his trade deals have no legal basis.' A note from Yardeni Research on Wednesday also pointed out that the administration is becoming increasingly concerned about losing the court case. The letter from the Justice Department officials appears to anticipate that they will lose the case as they are asking for a stay if the court goes against them. There will be 'messy' consequences if reciprocal tariffs are struck down, according to Yardeni, as Trump needs the revenue from tariffs to reduce the budget deficit and help to lower bond yields. 'If he loses in court, these yields might move higher. Stock prices might decline on this news initially due to a new round of policy uncertainty,' the note said. 'So the dire tone in the letter is understandable, even though it is a wee bit over the top.' This story was originally featured on
Yahoo
2 hours ago
- Yahoo
Smart Reads of the Week: Top Stocks, REITs, and Market Moves to Watch
The stock market continues to power ahead, with both Singapore and US equities presenting fresh opportunities. From top-performing stocks of the past decade to high-potential growth plays riding the AI and digitalisation wave, this week's selection covers strategies for both capital gains and income investors. We also explore the winners and losers from Singapore's telco shake-up, and highlight blue-chip and REIT ideas for long-term portfolios. Here are this week's top articles: The Top 10 Singapore Stocks Over the Past Decade – And Which Ones Still Look Good TodayA look back at the biggest winners over the last 10 years – and which ones could continue delivering strong returns in the years ahead. The Bull Market is Raging On: Should You Buy, Sell, or Hold Your Shares?With markets hitting new highs, we explore how to decide whether to lock in profits, stay invested, or add to your positions. 4 Singapore REITs Unlocking Value to Boost Their DPUThese REITs are enhancing their portfolios through acquisitions, asset enhancements, and strategic moves to grow unitholder returns. 5 US Technology Growth Stocks to Ride the Digitalisation and AI WavesFrom cloud computing to AI, these US tech stocks are well-placed to benefit from powerful secular trends. Singapore's Telco Consolidation: Who Are the Winners and Losers?The local telco landscape is evolving fast – here's what it means for the major players and their investors. Earn While You Sleep: Build Passive Income with These 3 Singapore Dividend StocksLooking for reliable dividend payers? These companies offer a steady stream of income alongside capital stability. 4 Singapore Blue-Chip Stocks That You Can Own for LifeStalwarts with enduring business models that could anchor your portfolio for decades. SGX Added Two More Hong Kong Singapore Depository Receipts: Here's What You Need to KnowAn update on SGX's growing list of Hong Kong SDRs, offering investors a gateway to more cross-border opportunities. Here's the best way to spend 5 minutes each week: Smart Reads. It gives you a fast, focused investing roundup so you don't waste hours scrolling through the news. We handpick the best stories, ideas, and market updates that matter. Whether it's dividend gems, capital growth plays, or key market shifts, you get them all in one email for free. Click here to join our community in Smart Reads, your smartest 15-minute read of the week. Follow us on Facebook, Instagram and Telegram for the latest investing news and analyses! The post Smart Reads of the Week: Top Stocks, REITs, and Market Moves to Watch appeared first on The Smart Investor. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
US will dodge recession, but Trump's policies will slow economic growth: Report
President Donald Trump's aggressive economic policies will likely significantly slow U.S. growth and push up inflation but stop short of causing a recession or 'stagflation' – the dire scenarios that forecasters envisioned before he took office, a report says. 'The totality of the policies does not push the economy to the brink of recession but it significantly diminishes growth' during Trump's four-year term, said economist Justin Begley of Moody's Analytics. He added, 'It's not yet stagflation but it's edging that way.' Stagflation is an economy characterized by high inflation, slow or stagnant growth and high unemployment – an unusual and toxic cocktail. Typically, a sluggish economy leads to low inflation, allowing the Federal Reserve to cut interest rates to stimulate more borrowing and activity. The Fed, however, faces a dilemma because lowering rates to bolster a softening labor market could further drive up inflation. Consumer price increases generally have eased substantially after a pandemic-related spike but recently edged higher, in part because of Trump's sweeping import levies. His policies are imposing countervailing forces on the economy. Tax cuts and increased spending on border security and defense are set to juice growth. But those positive catalysts are expected to be more than offset by the tariffs, a historic immigration crackdown, layoffs of hundreds of thousands of federal workers and big cuts to social services programs such as Medicaid and food stamps, Begley said. During Trump's presidential race against former Vice President Kamala Harris last year, Moody's, among other research firms, predicted Trump's economic blueprint would spark a recession by mid-2025. Moody's has updated its forecast in part because the contours of his plan recently have become more clearly defined, Begley said. 'We have a better view where things are going,' he said. For example, high double-digit tariffs are in place for steel and aluminum, foreign cars and Chinese imports. And the White House has reached deals with trading partners such as Japan, South Korea, Vietnam and the UK that set tariffs at 10% to 20%. Trump's deportations and constraints on Southern border crossings are well under way. And his huge budget bill, which he signed into law on July 4, expanded his 2017 tax cuts, beefed up military and border security outlays, and slashed some entitlement spending. All told, Moody's projects Trump's policies will reduce economic growth by an average 0.4 percentage points annually – nearly half a point – during his term. That would leave the economy expanding an average 1.7% annually over the four years, with growth bottoming at 1.4% next year and peaking at 2.2% in 2028. The economy grew at an annual rate of 1.2% the first half of 2025. It's projected to grow at slightly less than a 1% pace in the second half, according to economists surveyed by Wolters Kluwer Blue Chip Economic Indicators. By contrast, the economy averaged 2.3% growth the decade after the Great Recession of 2007-2009 and 3.5% during former president Joe Biden's term. The latter, however, included unusually strong gains as the nation emerged from the pandemic recession. In 2024, Biden's last year in office, the economy grew a healthy 2.8%. Growth had been expected to downshift no matter who won the 2024 election as a post-COVID-19 surge in consumer demand petered out, Americans depleted government pandemic aid and other government stimulus measures faded. But by the end of Trump's term in 2028, the economy will be 1.3% smaller than if his policies had not been enacted, Begley wrote in a report. Also, the unemployment rate is expected to peak at 4.7% in 2027 before falling to 4.4% by the time Trump leaves office. Without his policies, unemployment would broadly hold steady at about 4% and there would be about 885,000 additional jobs, Moody's said. Trump's policies similarly are poised to push up inflation by an average of nearly half a percentage point a year. That would leave annual inflation averaging 2.6% during Trump's term and peaking at 3.1% in 2026, based on the Commerce Department's personal consumption expenditures price index. Inflation then would decline and nearly reach the Fed's 2% goal in 2028, the last year of his term. Absent the president's policies, inflation would achieve the Fed's target next year, Begley's analysis shows. Tariffs, by far, represent both the biggest drag on growth and the largest contributor to inflation, Begley said. Companies are expected to pass most of the costs of the duties to consumers, driving up prices. And that's expected to sap their buying power and reduce consumption, which makes up 70% of economic activity. Without the tariffs, the net effects of Trump's policies on growth would be slightly positive, Begley said. The benefits of tax cuts and increased defense and border spending would outweigh the toll taken by the immigration crackdown, federal layoffs and cutbacks to Medicaid and food stamps, he said. Another big hit comes from the deportations. Like the tariffs, the immigration crackdown is projected to both curtail growth and boost inflation. A reduced supply of workers in industries such as construction, agriculture and hospitality is expected to drive up wages and prices. And a smaller population of immigrants means less consumer spending. Here's why Moody's forecast of the effects of Trump's policies is less dire than it was before he took office: Although Trump's tariffs are higher than anticipated, Moody's expected more significant retaliation from foreign countries that would batter U.S. manufacturers' exports. At least so far, those nations have taken a more restrained approach. Moody's figured the Trump administration would seek to deport about 1 million immigrants who lack permanent legal status each year. But Begley said that has proven logistically challenging. Goldman Sachs estimates monthly deportations have averaged an annualized pace of about 600,000. Although Trump vowed during his campaign to eliminate taxes on tips and overtime, Moody's didn't necessarily expect him to follow through. The budget bill, however, scraps taxes on tips up to $25,000 a year and over time up to $12,500. This article originally appeared on USA TODAY: Will the US dodge a recession? Economist weighs in on Trump policies Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
